J. Vilček

发表

Induction of the transcription factor IRF-1 and interferon-beta mRNAs by cytokines and activators of second-messenger pathways.

T. Taniguchi, T. Fujita, L. Reis, 1989, Proceedings of the National Academy of Sciences of the United States of America.

From IFN to TNF: a journey into realms of lore

J. Vilček, 2009, Nature Immunology.

First Demonstration of the Role of TNF in the Pathogenesis of Disease

J. Vilček, 2008, The Journal of Immunology.

Historical review: Cytokines as therapeutics and targets of therapeutics.

Jan Vilcek, M. Feldmann, J. Vilček, 2004, Trends in pharmacological sciences.

Fibroblast growth enhancing activity of tumor necrosis factor and its relationship to other polypeptide growth factors

J. Vilček, R. Feinman, V. Palombella, 1986, The Journal of experimental medicine.

Tumor necrosis factor. New insights into the molecular mechanisms of its multiple actions.

J. Vilček, T. Lee, 1991, The Journal of biological chemistry.

Cytokine-induced gene expression at the crossroads of innate immunity, inflammation and fertility: TSG-6 and PTX3/TSG-14.

J. Vilček, H. Wisniewski, 2004, Cytokine & growth factor reviews.

TSG‐14 transgenic mice have improved survival to endotoxemia and to CLP‐induced sepsis

L. Reis, J. Vilček, R. Gomes, 2001, Journal of leukocyte biology.

Downregulation of interleukin 8 gene expression in human fibroblasts: unique mechanism of transcriptional inhibition by interferon.

J. Vilček, T. Lee, I. Oliveira, 1992, Proceedings of the National Academy of Sciences of the United States of America.

TSG-14, a tumor necrosis factor- and IL-1-inducible protein, is a novel member of the pentaxin family of acute phase proteins.

J. Vilček, T. Lee, G. Lee, 1993, Journal of immunology.

Relationship of TSG-14 protein to the pentraxin family of major acute phase proteins.

J. Vilček, T. Lee, A. R. Goodman, 1994, Journal of immunology.

Profile of Angelika Amon, winner of the 2019 Vilcek Prize in Biomedical Science

J. Vilček, P. Nair, 2019, Proceedings of the National Academy of Sciences.

TSG-6 expression in human articular chondrocytes. Possible implications in joint inflammation and cartilage degradation.

J. Vilček, M. Lotz, H. Wisniewski, 1996, Arthritis and rheumatism.

CCAAT box enhancer binding protein alpha (C/EBP-alpha) stimulates kappaB element-mediated transcription in transfected cells.

J. Vilček, I. Vietor, I. Oliveira, 1996, The Journal of biological chemistry.

CCAAT Box Enhancer Binding Protein (C/EBP-) Stimulates B Element-mediated Transcription in Transfected Cells (*)

J. Vilček, I. Vietor, I. Oliveira, 1996, The Journal of Biological Chemistry.

Induction of β 2-interferon by tumor necrosis factor: A homeostatic mechanism in the control of cell proliferation

P. Sehgal, J. Vilček, D. Henriksen-DeStefano, 1986, Cell.

Isolation and characterization of eight tumor necrosis factor-induced gene sequences from human fibroblasts

J. Vilček, T. Lee, E. Ziff, 1990 .

Antiviral Action of TNF in Human Fibroblasts Requires the Presence of Subeffective Concentrations of Classical Interferon‐β a

T. Taniguchi, Jian-xin Lin, T. Fujita, 1989 .

Interleukin 6: a multifunctional cytokine regulating immune reactions and the acute phase protein response.

J. Vilček, J. Le, J. Le, 1989, Laboratory investigation; a journal of technical methods and pathology.

Mechanisms and significance of the mitogenic and antiviral actions of TNF.

L. Reis, J. Vilček, R. Feinman, 1988, Annales de l'Institut Pasteur. Immunology.

Mitogenic action of tumor necrosis factor in human fibroblasts: Interaction with epidermal growth factor and platelet‐derived growth factor

J. Mendelsohn, J. Vilček, V. Palombella, 1988, Journal of cellular physiology.

Interleukin-1 can inhibit interferon-beta synthesis and its antiviral action: comparison with tumor necrosis factor.

P. Sehgal, J. Vilček, S. Yamazaki, 1988, Journal of interferon research.

A cytokine network in human diploid fibroblasts: interactions of beta-interferons, tumor necrosis factor, platelet-derived growth factor, and interleukin-1

J. Vilček, M. Kohase, L. May, 1987 .

Regulation of Human Fibroblast Growth by Autocrine Interferon-Beta

P. Sehgal, J. Vilček, M. Tsujimoto, 1987 .

Inverse interference by growth factors.

J. Vilček, 1987, Journal of interferon research.

Human beta 2 interferon and B-cell differentiation factor BSF-2 are identical.

P. Sehgal, J. Vilček, I. Tamm, 1987, Science.

Tumor necrosis factor: Receptor binding and mitogenic action in fibroblasts

J. Vilček, V. Palombella, M. Tsujimoto, 1987, Journal of cellular physiology. Supplement.

Regulation of Cell Growth by Interferon and Tumor Necrosis Factor

J. Vilček, 1987 .

Characterization and affinity crosslinking of receptors for tumor necrosis factor on human cells.

J. Vilček, R. Feinman, M. Tsujimoto, 1986, Archives of biochemistry and biophysics.

Production of High-Titered Interferon in Cultures of Human Diploid Cells

J. Vilček, E. A. Havell, E. Havell, 1972, Antimicrobial Agents and Chemotherapy.

Two antigenically distinct species of human interferon.

J. Vilček, E. A. Havell, B. Berman, 1975, Proceedings of the National Academy of Sciences of the United States of America.

Selection of new human foreskin fibroblast cell strains for interferon production.

J. Vilček, W. Douglas, E. Havell, 1978, Advances in experimental medicine and biology.

Natural and recombinant Escherichia coli-derived interferon-gamma differ in their reactivity with monoclonal antibody.

J. Vilček, C. Feit, B. Rubin, 1984, Journal of immunology.

Tumor necrosis factor: specific binding and internalization in sensitive and resistant cells.

J. Vilček, M. Tsujimoto, Y. Yip, 1985, Proceedings of the National Academy of Sciences of the United States of America.

Enhancement of cAMP levels and of protein kinase activity by tumor necrosis factor and interleukin 1 in human fibroblasts: role in the induction of interleukin 6.

J. Vilček, Y. Yip, Y. Zhang, 1988, Proceedings of the National Academy of Sciences of the United States of America.

Use of monoclonal antibodies as sensitive and specific probes for biologically active human gamma-interferon.

J. Vilček, T. Chang, V. Liu, 1984, Proceedings of the National Academy of Sciences of the United States of America.

Cell Stress and MKK6b-mediated p38 MAP Kinase Activation Inhibit Tumor Necrosis Factor-induced IκB Phosphorylation and NF-κB Activation*

Jiahuai Han, J. Vilček, D. Alpert, 1999, The Journal of Biological Chemistry.

Altered molecular species of human interferon produced in the presence of inhibitors of glycosylation.

J. Vilček, S. Yamazaki, E. Havell, 1977, The Journal of biological chemistry.

A prize for the foreign‐born

J. Vilček, B. Cronstein, 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

The mouse/human chimeric monoclonal antibody cA2 neutralizes TNF in vitro and protects transgenic mice from cachexia and TNF lethality in vivo.

G. Kollias, J. Ghrayeb, P. Daddona, 1995, Cytokine.

Transcriptional regulation of TSG6, a tumor necrosis factor- and interleukin-1-inducible primary response gene coding for a secreted hyaluronan-binding protein.

T. Shows, L. Klampfer, J. Vilček, 1993, The Journal of biological chemistry.

Activation of p38 mitogen-activated protein kinase by sodium salicylate leads to inhibition of tumor necrosis factor-induced IkappaB alpha phosphorylation and degradation.

J. Vilček, E. Skolnik, D. Alpert, 1998, Molecular and cellular biology.

Acid-labile human leukocyte interferon in homosexual men with Kaposi's sarcoma and lymphadenopathy.

J. Goedert, R. Friedman, J. Vilček, 1982, The Journal of infectious diseases.

Induction of membrane-associated interleukin 1 by tumor necrosis factor in human fibroblasts.

J. Vilček, U. Gubler, J. Le, 1987, Journal of immunology.

Mitogenic and cytotoxic actions of tumor necrosis factor in BALB/c 3T3 cells. Role of phospholipase activation.

J. Vilček, V. Palombella, 1989, The Journal of biological chemistry.

Synergistic Actions of Interferons and Tumor Necrosis Factor

J. Vilček, R. Feinman, 1988 .

Tumor necrosis factor provokes superoxide anion generation from neutrophils.

G. Weissmann, S. Yokota, J. Vilček, 1986, Biochemical and biophysical research communications.

Synthesis of interleukin 6 (interferon-beta 2/B cell stimulatory factor 2) in human fibroblasts is triggered by an increase in intracellular cyclic AMP.

J. Vilček, Y. Zhang, J. X. Lin, 1988, The Journal of biological chemistry.

Tumor necrosis factor and interleukin 1: cytokines with multiple overlapping biological activities.

J. Vilček, J. Le, 1987, Laboratory investigation; a journal of technical methods and pathology.

Stimulation of Interleukin‐6 mRNA Levels by Tumor Necrosis Factor and Interleukin‐1

Jian-xin Lin, J. Vilček, Y. Yip, 1989 .

“America First” Will Destroy U.S. Science

M. Merad, J. Vilček, B. Brown, 2020, Cell.

Interleukin 2-dependent and interleukin 2-independent pathways of regulation of thymocyte function by interleukin 6.

T. Hirano, L. Reis, J. Vilček, 1988, Proceedings of the National Academy of Sciences of the United States of America.

Activation of NF‐κB may be necessary but is not sufficient for induction of H‐2 antigens by TNF in J558L murine myeloma cells

J. Wolchok, J. Vilček, A. R. Goodman, 1994, Journal of leukocyte biology.

Interrelationships of human interferon-gamma with lymphotoxin and monocyte cytotoxin

B. Aggarwal, J. Vilček, D. Henriksen-DeStefano, 1984, The Journal of experimental medicine.

Characterization of human tumor necrosis factor produced by peripheral blood monocytes and its separation from lymphotoxin

B. Aggarwal, J. Vilček, D. Henriksen-DeStefano, 1985, International journal of cancer.

Superinduction of interferon with metabolic inhibitors: possible mechanisms and practical applications.

J. Vilček, M. Kohase, E. Havell, 1976, The Journal of infectious diseases.

Monoclonal antibodies as structural probes for oligomeric human interferon-gamma.

J. Vilček, T. Chang, Y. Yip, 1985, Journal of interferon research.

Comparative studies of the biological activities of human tumor necrosis factor and its derivatives.

J. Vilček, M. Tsujimoto, H. Nakazato, 1987, Journal of biochemistry.

Tumor necrosis factors. Structure, function, and mechanism of action.

B. Aggarwal, J. Vilček, 1992, Immunology series.

Tumor necrosis factor receptors in HeLa cells and their regulation by interferon-gamma.

J. Vilček, M. Tsujimoto, 1986, The Journal of biological chemistry.

Modulation of lymphocyte proliferation and immunoglobulin synthesis by interferon-gamma and "type I" interferons.

D. Siegel, J. Vilček, J. Le, 1986, Cellular immunology.

Transcriptional basis for the differences in inducible nitric oxide synthase (iNOS) expression between nonmetastatic and metastatic murine melanoma cell lines.

J. Vilček, J. Gerecitano, M. Perle, 1999, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

Cell-free synthesis of human interferon.

S. Pestka, J. Vilček, J. Mcinnes, 1975, Proceedings of the National Academy of Sciences of the United States of America.

Induction and decay of human fibroblast interferon mRNA.

S. Pestka, J. Vilček, E. Havell, 1977, Proceedings of the National Academy of Sciences of the United States of America.

Synthesis of human interferon by Xenopus laevis oocytes: two structural genes for interferons in human cells.

S. Pestka, J. Vilček, E. Havell, 1977, Proceedings of the National Academy of Sciences of the United States of America.

Antibodies to chromosome 21 coded cell surface components block binding of human α interferon but not λ interferon to human cells

F. Ruddle, J. Vilček, C. Baglioni, 1984 .

Tumor necrosis factor and interleukin-1 cause a rapid and transient stimulation of c-fos and c-myc mRNA levels in human fibroblasts.

J. Vilček, J. X. Lin, 1987, The Journal of biological chemistry.

My fifty years with interferon.

J. Vilček, 2007, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

An Interferon-like Substance released from Tick-borne Encephalitis Virus-infected Chick Embryo Fibroblast Cells

J. Vilček, 1960, Nature.

IL-6 inhibits lipopolysaccharide-induced tumor necrosis factor production in cultured human monocytes, U937 cells, and in mice.

J. Vilček, D. Aderka, J. Le, 1989, Journal of immunology.

IRF1: a deus ex machina in TH1 differentiation

J. Vilček, D. Unutmaz, 2008, Nature Immunology.

Induction of HLA class I mRNA by cytokines in human fibroblasts: comparison of TNF, IL-1 and IFN-beta.

J. Vilček, J. Wolchok, 1992, Cytokine.

Effect of primary amines on interferon action.

B. Tycko, F. Maxfield, J. Vilček, 1982, Virology.

Interleukin-6 induction by tumor necrosis factor and interleukin-1 in human fibroblasts involves activation of a nuclear factor binding to a kappa B-like sequence

J. Vilček, Y. Zhang, J. X. Lin, 1990, Molecular and cellular biology.

Entrapment of human leukocyte interferon in the aqueous interstices of liposomes

G. Weissmann, J. Vilček, P. Anderson, 1981, Infection and immunity.

The synthesis and actions of mouse and human interferons in mouse-human hybrid cells.

J. Vilček, C. Croce, E. Havell, 1978, Virology.

Cellular binding characteristics of human interferon.

J. Vilček, B. Berman, 1974, Virology.

Post-Transcriptional Control of Interferon Synthesis

J. Vilček, M. Ng, 1971, Journal of virology.

On the mechanism of enhancement of human interferon production by actinomycin D and cycloheximide.

P. Sehgal, J. Vilček, I. Tamm, 1976, Virology.

Regulation of human interferon production. I. Superinduction by 5, 6-dichloro-1-beta-D-ribofuranosylbenzimidazole.

P. Sehgal, J. Vilček, I. Tamm, 1976, Virology.

Regulation of human interferon production. II. Inhibition of interferon messenger RNA synthesis by 5, 6-dichloro-1-beta-D-ribofuranosylbenzimidazole.

P. Sehgal, J. Vilček, I. Tamm, 1976, Virology.

Distinguishing characteristics of interferon induction with poly(I)-poly(C) and Newcastle disease virus in human cells.

J. Vilček, L. W. Mozes, 1975, Virology.

Production of human alpha- and beta- interferons by human-rodent hybrids.

J. Vilček, A. Meager, T. Hayes, 1982, Journal of interferon research.

Synthesis of two distinct interferons by human fibroblasts.

J. Vilček, E. A. Havell, T. Hayes, 1978, Virology.

Cell‐type‐specific activation of c‐Jun N‐terminal kinase by salicylates

J. Vilček, E. Skolnik, D. Alpert, 1999, Journal of cellular physiology.

NF-IL6 and AP-1 cooperatively modulate the activation of the TSG-6 gene by tumor necrosis factor alpha and interleukin-1

S. Chen‐Kiang, L. Klampfer, J. Vilček, 1994, Molecular and cellular biology.

Bacterial lipopolysaccharide-induced interferon-gamma production: roles of interleukin 1 and interleukin 2.

J. Vilček, D. Henriksen-DeStefano, J. Le, 1986, Journal of immunology.

Inhibition of Glucocorticoid Receptor-mediated Transcriptional Activation by p38 Mitogen-activated Protein (MAP) Kinase*

Z. Szatmáry, M. Garabedian, J. Vilček, 2004, Journal of Biological Chemistry.

Interferon-beta induces metalloproteinase mRNA expression in human fibroblasts. Role of activator protein-1.

J. Vilček, T. Lee, P. Sciavolino, 1994, The Journal of biological chemistry.

Human interferon-gamma is internalized and degraded by cultured fibroblasts.

J. Vilček, Y. Yip, P. Anderson, 1983, The Journal of biological chemistry.

Specific binding of 125I-human interferon-gamma to high affinity receptors on human fibroblasts.

J. Vilček, Y. Yip, P. Anderson, 1982, The Journal of biological chemistry.

Tumor necrosis factor-induced downregulation of its receptors in HeLa cells.

J. Vilček, M. Tsujimoto, 1987, Journal of biochemistry.

Novel interferons

J. Vilček, 2003, Nature Immunology.

Why are rabbits uniquely sensitive to myxoma virus? Cherchez l'interferon!

J. Vilček, 2004, Nature Immunology.

Activation of human monocyte cytotoxicity by natural and recombinant immune interferon.

J. Vilček, Y. Yip, W. Prensky, 1983, Journal of immunology.

Interferon-gamma enhances expression of cellular receptors for tumor necrosis factor.

J. Vilček, M. Tsujimoto, Y. Yip, 1986, Journal of immunology.

Renal deposition of alpha interferon in systemic lupus erythematosus

N. Ordóñez, J. Vilček, S. Panem, 1983, Infection and immunity.

ALPHA INTERFERON AND ANTIBODY TO ALPHA INTERFERON IN SYSTEMIC LUPUS ERYTHEMATOSUS

J. Vilček, I. Check, S. Panem, 1982 .

Amelioration of collagen-induced arthritis in DBA/1J mice by recombinant TSG-6, a tumor necrosis factor/interleukin-1-inducible protein.

J. Vilček, G. Thorbecke, M. Klein, 2000, Arthritis and rheumatism.

Protodyne: an immunostimulatory protein component, prepared from gram-positive Bacillus subtilis.

J. Vilček, C. Dinarello, J. V. D. van der Meer, 1992, Developments in biological standardization.

Persistent Tumor Necrosis Factor Signaling in Normal Human Fibroblasts Prevents the Complete Resynthesis of IκB-α*

J. Vilček, D. Poppers, P. Schwenger, 2000, The Journal of Biological Chemistry.

Foreign minds, fenceless imagination: The 2013 Vilcek Foundation Prizes

J. Vilček, P. Nair, 2013, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Le interferon production by human fibroblasts.

J. Vilček, Y. Yip, T. Hayes, 1979, Virology.

Antibodies to alpha-interferon in a patient with systemic lupus erythematosus.

J. Vilček, I. Check, S. Panem, 1982, Journal of immunology.

Induction of interferon synthesis by synthetic double-stranded polynucleotides

J. Vilček, M. Ng, A. Friedman-kien, 1968, Journal of virology.

Potentiation of the action of interferon by extracts of Escherichia coli.

J. Vilček, M. Ng, 1967, Virology.

Activation of the TSG-6 Gene by NF-IL6 Requires Two Adjacent NF-IL6 Binding Sites (*)

S. Chen‐Kiang, L. Klampfer, J. Vilček, 1995, The Journal of Biological Chemistry.

Interferons and the immune system

J. Vilček, E. Demaeyer, 1984 .

Synthesis and biological characterization of a covalent conjugate between interferon and ricin toxin B chain.

J. Vilček, P. Anderson, 1982, Virology.

TSG-6 Protein Binding to Glycosaminoglycans

E. Snitkin, J. Vilček, H. Wisniewski, 2005, Journal of Biological Chemistry.

Cytolytic activity of interferon‐gamma and its synergism with 5‐fluorouracil

J. Vilček, J. Le, Yum K. Yip, 1984, International journal of cancer.

Blocking of interferon action by a component of normal serum

T. Rossman, J. Vilček, 2005, Archiv für die gesamte Virusforschung.

Interaction of interferon with chick embryo cells

D. Lowy, J. Vilček, 2005, Archiv für die gesamte Virusforschung.

PRODUCTION OF INTERFERON BY NEWBORN AND ADULT MICE INFECTED WITH SINDBIS VIRUS.

J. Vilček, 1964, Virology.

Non-apoptotic Signaling Pathways Activated by Soluble Fas Ligand in Serum-starved Human Fibroblasts

Sun-Mi Park, J. Yoon, J. Vilček, 2001, The Journal of Biological Chemistry.

Generation and Characterization of Human T-Cell Hybridomas That Constitutively Produce Immune Interferon

J. Vilček, W. Prensky, J. Le, 1985 .

Synthesis of alpha and gamma interferons by a human cutaneous lymphoma with helper T-cell phenotype.

J. Vilček, W. Prensky, J. Le, 1982, Cellular Immunology.

Gems from Distant Shores The 2012 Vilcek Foundation Prizes

J. Vilček, P. Nair, 2012, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Mycobacterium bovis infection of mice lacking receptors for interferon-gamma or for transcription factor IRF-1.

J. Vilček, R. Kamijo, D. Shapiro, 1994, Journal of interferon research.

Cytokine and Growth Factor Reviews to be published six times a year

M. Sporn, J. Vilček, 2002 .

Transcriptional inhibition of the interleukin-8 gene by interferon is mediated by the NF-kappa B site

K. Matsushima, N. Mukaida, J. Vilček, 1994, Molecular and cellular biology.

Phase Ib Trial of Granulocyte‐Macrophage Colony‐Stimulating Factor Combined with Murine Monoclonal Antibody R24 in Patients with Metastatic Melanoma

J. Vilček, D. Peace, A. Chachoua, 1994, Journal of immunotherapy with emphasis on tumor immunology : official journal of the Society for Biological Therapy.

Three molecular weight forms of natural human interferon-gamma revealed by immunoprecipitation with monoclonal antibody.

J. Vilček, Y. Yip, B. Rubin, 1984, The Journal of biological chemistry.

Defective gamma-interferon production in peripheral blood leukocytes of patients with acute tuberculosis

J. Vilček, D. Henriksen-DeStefano, A. Klion, 1986, Journal of Clinical Immunology.

Interferon-γ enhances target cell sensitivity to monocyte killing

D. Siegel, J. Vilček, R. Feinman, 1986 .

Purified human interleukin-2 enhances induction of immune interferon.

K. Welte, J. Vilček, M. Palladino, 1983, Cellular immunology.

TSG-6: an IL-1/TNF-inducible protein with anti-inflammatory activity.

J. Vilček, H. Wisniewski, Jan Vilcek, 1997, Cytokine & growth factor reviews.

TSG-6, an arthritis-associated hyaluronan binding protein, forms a stable complex with the serum protein inter-alpha-inhibitor.

J. Vilček, J. Oppenheim, W. Burgess, 1994, Biochemistry.

TSG-6: a TNF-, IL-1-, and LPS-inducible secreted glycoprotein associated with arthritis.

L. Klampfer, J. Vilček, T. Lee, 1993, Journal of immunology.

TSG-6: A Novel Secretory Protein Inducible by Tumor Necrosis Factor or Interleukin-1 in Fibroblasts and Mononuclear Cells

L. Klampfer, J. Vilček, T. Lee, 1993 .

Plasmodium berghei sporozoites are mitogenic for murine T cells, induce interferon, and activate natural killer cells.

J. Vilček, R. Nussenzweig, A. Cochrane, 1984, Journal of immunology.

Immune interferon induction by monoclonal antibody specific for human T cells.

J. Vilček, Y. Yip, R. H. Pang, 1981, Cellular immunology.

TSG-6, a glycoprotein associated with arthritis, and its ligand hyaluronan exert opposite effects in a murine model of inflammation

J. Vilček, B. Cronstein, J. Hua, 2006, Pflügers Archiv.

Promoter Structure and Transcriptional Activation of the Murine TSG-14 Gene Encoding a Tumor Necrosis Factor/Interleukin-1-inducible Pentraxin Protein (*)

L. Klampfer, J. Vilček, A. R. Goodman, 1995, The Journal of Biological Chemistry.

Induction of human interferon gamma with phorbol esters and phytohemagglutinin.

J. Vilček, Y. Yip, J. Le, 1986, Methods in enzymology.

Generation of nitric oxide and induction of major histocompatibility complex class II antigen in macrophages from mice lacking the interferon gamma receptor.

J. Vilček, S. Huang, M. Aguet, 1993, Proceedings of the National Academy of Sciences of the United States of America.

Attempts to induce interferon production by IdUrd induction and EBV superinfection in human lymphoma lines and their hybrids.

G. Klein, J. Vilček, 1980, The Journal of general virology.

Lymphokine-mediated activation of human monocytes: neutralization by monoclonal antibody to interferon-gamma.

J. Vilček, J. Le, 1984, Cellular immunology.

Monoclonal antibodies to human immune interferon and their application for affinity chromatography.

J. Vilček, J. Le, B. Barrowclough, 1984, Journal of immunological methods.

Stimulation of human gamma interferon production by diterpene esters

J. Vilček, J. Oppenheim, Y. Yip, 1981, Infection and immunity.

Suppression of the Intracellular Growth of Shigella flexneri in Cell Cultures by Interferon Preparations and Polyinosinic-Polycytidylic Acid

J. Vilček, E. A. Havell, A. Friedman-kien, 1972, Infection and immunity.

Exogenous Interferon protects Mice against Plasmodium berghei Malaria

J. Vilček, R. Jahiel, R. Nussenzweig, 1970, Nature.

Interferon Inducers Protect Mice against Plasmodium berghei Malaria

J. Vilček, R. Jahiel, J. Vanderberg, 1968, Science.

Production of human fibroblast interferon in the presence of the glycosylation inhibitor tunicamycin.

J. Vilček, Y. Yip, 1981, Methods in enzymology.

Regulation of IFN-gamma induction in human peripheral blood cells by exogenous and endogenously produced interleukin 2.

D. Siegel, J. Vilček, D. Henriksen-DeStefano, 1985, Journal of immunology.

Human T cell hybridomas secreting immune interferon.

J. Vilček, W. Prensky, C. Saxinger, 1982, Proceedings of the National Academy of Sciences of the United States of America.

Purification of two subspecies of human gamma (immune) interferon.

J. Vilček, Y. Yip, C. Urban, 1982, Proceedings of the National Academy of Sciences of the United States of America.

ROLE OF INTERFERON IN AIDS a

E. Gelmann, R. Friedman, J. Vilček, 1984, Annals of the New York Academy of Sciences.

Inhibitory effects of human leukocyte and fibroblast interferons on normal and chronic myelogenous leukemic granulocytic progenitor cells.

J. Vilček, J. Holland, T. Ohnuma, 1981, Oncology.

Pathways of heat shock protein 28 phosphorylation by TNF in human fibroblasts.

J. Vilček, I. Vietor, 1994, Lymphokine and cytokine research.

Immune response in mice that lack the interferon-gamma receptor.

R. Zinkernagel, J. Vilček, S. Huang, 1993, Science.

Biological functions of IFN-gamma and IFN-alpha/beta: lessons from studies in gene knockout mice.

J. Vilček, R. Kamijo, D. Shapiro, 1994, [Hokkaido igaku zasshi] The Hokkaido journal of medical science.

Gamma interferon synthesis by human thymocytes and T lymphocytes inhibited by cyclosporin A.

J. Vilček, G. H. Reem, L. A. Cook, 1983, Science.

Protective effect of interferon inducers on Plasmodium berghei malaria.

J. Vilček, R. Jahiel, J. Vanderberg, 1969, The American journal of tropical medicine and hygiene.

Mice That Lack the Interferon- 7 Receptor Have Profoundly Altered Responses to Infection with Bacillus Calmette-Gu6rin and Subsequent Ch-ilenge with Lipopolysaccharide By Ryutaro Kamijo,* Junming l.e,* Deborah Shapiro,*

J. Vilček, S. Huang, M. Aguet, 1993 .

Mollucum contagiosum virus in adult human skin cultures. An electron microscopic study.

J. Vilček, P. Prose, A. Friedman-kien, 1969, The American journal of pathology.

Suppression oftheIntracellular GrowthofShigella flexneri inCell Cultures byInterferon Preparations andPolyinosinic-Pol ycytidylic

J. Vilček, E. A. Havell, A. Friedman-kien, 1972 .

[15] Production of rabbit interferon

J. Vilček, L. W. Mozes, 1981 .

Pharmacokinetic properties of human fibroblast and leukocyte interferon in rabbits

J. Vilček, Y. Yip, I. Sulea, 1980, Journal of clinical microbiology.

Gamma interferon induction in human thymocytes activated by lectins and B cell lines

J. Vilček, G. H. Reem, D. Henriksen, 1982, Infection and immunity.

Stabilization of interferon messenger RNA activity by treatment of cells with metabolic inhibitors and lowering of the incubation temperature.

J. Vilček, E. Havell, 1973, Proceedings of the National Academy of Sciences of the United States of America.

Enhancement of human interferon production by neutral red and chloroquine: analysis of inhibition of protein degradation and macromolecular synthesis

P. Sehgal, J. Vilček, I. Tamm, 1975, The Journal of experimental medicine.

Sodium salicylate induces apoptosis via p38 mitogen-activated protein kinase but inhibits tumor necrosis factor-induced c-Jun N-terminal kinase/stress-activated protein kinase activation.

J. Vilček, E. Skolnik, I. Vietor, 1997, Proceedings of the National Academy of Sciences of the United States of America.

Suppression of human interferon production by inhibitors of glycosylation.

J. Vilček, E. Falcoff, E. A. Havell, 1975, Virology.

Inhibition of Growth of Bi 6 Murine Malignant Melanomaby Exogenous Interferon

A. Kopf, R. Bart, J. Vilček, 1980 .

Role of interferon in the anti-melanoma effects of poly (I).poly (C) and Newcastle disease virus.

A. Kopf, R. Bart, J. Vilček, 1973, Nature: New biology.

Interferon induction by vesicular stomatitis virus and its role in virus replication

J. Vilček, S. Yamazaki, E. Havell, 1977, Infection and immunity.

Cellular Mechanisms of Interferon Production

J. Vilček, 1970, The Journal of general physiology.

Control of Interferon Synthesis: Effect of Diethyl-aminoethyl-Dextran on Induction by Polyinosinic-Polycytidylic Acid

J. Vilček, E. Havell, S. L. Barmak, 1972, Journal of virology.

Increased Interferon Production in Human Cells Irradiated with Ultraviolet Light

J. Vilček, E. A. Havell, M. L. Gradoville, 1974, Infection and immunity.

Characteristics of human lymphoblastoid (Namalva) interferon.

J. Vilček, Y. Yip, E. Havell, 1978, The Journal of general virology.

Tumor necrosis factor is an important mediator of tumor cell killing by human monocytes.

J. Vilček, R. Feinman, M. Tsujimoto, 1987, Journal of immunology.

A cytokine network in human diploid fibroblasts: interactions of beta-interferons, tumor necrosis factor, platelet-derived growth factor, and interleukin-1

J. Vilček, I. Tamm, M. Kohase, 1987, Molecular and cellular biology.

Determination of human T cell activity in response to allogeneic cells and mitogens. An immunochemical assay for gamma-interferon is more sensitive and specific than a proliferation assay.

J. Vilček, T. Chang, J. Le, 1986, Journal of immunological methods.

UNRESPONSIVENESS TO THE ACTION OF INTERFERON DEVELOPED IN PERSISTENTLY INFECTED L CELLS.

J. Vilček, D. Stanček, 1963, Life sciences.

Interferon Synthesis Post-Transcriptional Control of

J. Vilček, M. Ng, 2014 .

Inhibition of interferon production in human fibroblasts by a tumor promoting phorbol ester

J. Vilček, H. M. Frankfort, 2005, Archives of Virology.

Interferon Induction in Rabbit Cells Irradiated with UV Light

J. Vilček, L. W. Mozes, 1974, Journal of virology.

METABOLIC DETERMINANTS OF THE INDUCTION OF INTERFERON BY A SYNTHETIC DOUBLE‐STRANDED POLYNUCLEOTIDE IN RABBIT KIDNEY CELLS

J. Vilček, 1970 .

Differential Effects of Actinomycin D and Puromycin on the Release of Interferon induced by Double Stranded RNA

T. Rossman, J. Vilček, F. Varacalli, 1969, Nature.

Studies on an interferon from tickborne encephalitis virus-infected cells (IF). III. Antiviral action of IF.

J. Vilček, B. Rada, 1962, Acta virologica.

Virological studies in amyotrophic lateral sclerosis

J. Vilček, R. Carp, R. Kascsak, 1982, Muscle & nerve.

SPONTANEOUS PRODUCTION OF T (TYPE II) INTERFERON BY A MURINE RETICULUM‐CELL SARCOMA *

J. Vilček, N. Ponzio, K. Fitzgerald, 1980, Annals of the New York Academy of Sciences.

Molecular weight of human gamma interferon is similar to that of other human interferons.

J. Vilček, Y. Yip, C. Urban, 1982, Science.

Partial purification and characterization of human gamma (immune) interferon.

J. Vilček, Y. Yip, C. Urban, 1981, Proceedings of the National Academy of Sciences of the United States of America.

Effects of glycosidase treatment on the physicochemical properties and biological activity of human interferon-gamma.

J. Vilček, Y. Yip, P. Anderson, 1983, The Journal of biological chemistry.

Interferons: Physicochemical Properties and Control of Cellular Synthesis

J. Vilček, M. Ng, 1972 .

Production ofHigh-Titered Interferon inCultures ofHumanDiploid Cells

J. Vilček, 1972 .

Interferon induction with Newcastle disease virus in FS-4 cells: effect of priming with interferon and of virus inactivating treatments.

J. Vilček, M. Kohase, 1979, Japanese journal of medical science & biology.

Altered cellular responses to interferon induction by poly I · poly C: Priming and hyporesponsiveness in cells treated with interferon preparations

J. Vilček, S. L. Barmak, 2005, Archiv für die gesamte Virusforschung.

Studies on an interferon from tick-borne encephalitis virus-infected cells (IF). IV. Comparison of IF with interferon from influenza virus-infected cells.

J. Vilček, 1962, Acta virologica.

Systemic lupus erythematosus: presence in human serum of an unusual acid-labile leukocyte interferon.

R. Friedman, J. Vilček, J. Klippel, 1982, Science.

Initial interaction of human fibroblast and leukocyte interferons with FS-4 fibroblasts.

J. Vilček, L. J. Gardner, 1979, The Journal of general virology.

Influence of the Rate of Cell Growth and Cell Density on Interferon Action in Chick Embryo Cells

T. Rossman, J. Vilček, 1969, Journal of virology.

Human interferon production: superinduction by 5,6-dichloro-1-beta-D-ribofuranosylbenzimidazole

P. Sehgal, J. Vilček, I. Tamm, 1975, Science.

Induction of interference and interferon synthesis by non-replicating molluscum contagiosum virus.

J. Vilček, A. Friedman-kien, 1967, Journal of immunology.

Two molecular weight forms of human 2',5'-oligoadenylate synthetase have different activation requirements.

J. Vilček, P. Torrence, D. Ilson, 1986, Journal of interferon research.

Dexamethasone inhibits feedback regulation of the mitogenic activity of tumor necrosis factor, interleukin‐1, and epidermal growth factor in human fibroblasts

P. Sehgal, J. Vilček, M. Kohase, 1987, Journal of cellular physiology.

Infection of interferontreated cells with eastern equine encephalomyelitis virus and its ribonucleic acid.

J. Vilček, F. Sokol, V. Mayer, 1962, Virology.

There is more to hemorrhagic necrosis than tumor necrosis factor.

J. Vilček, J. Wolchok, 1991, Journal of the National Cancer Institute.

Cytokines: Wherefrom and Whereto

J. Vilček, 2005 .

CHAPTER 1 – The cytokines: an overview

J. Vilček, 2003 .

Profile of Dan Littman, winner of the 2016 Vilcek Prize in Biomedical Science

J. Vilček, P. Nair, 2016, Proceedings of the National Academy of Sciences.

Cytokine regulation of interleukin-6 gene expression in astrocytes involves activation of an NF-κ B-like nuclear protein

J. Vilček, E. Benveniste, Yihong Zhang, 1992, Journal of Neuroimmunology.

Activation of Thymocytes and T Cells by Interleukin‐6 a

J. Vilček, J. Le, Gay Fredrickson, 1989, Annals of the New York Academy of Sciences.

Inhibition of IκB Kinase Activity by Sodium Salicylate in Vitro Does Not Reflect Its Inhibitory Mechanism in Intact Cells*

J. Vilček, J Vilcek, D Alpert, 2000, The Journal of Biological Chemistry.

A novel secretory tumor necrosis factor-inducible protein (TSG-6) is a member of the family of hyaluronate binding proteins, closely related to the adhesion receptor CD44

Tae H. Lee, J. Vilček, T. Lee, 1992, The Journal of cell biology.

Tumor necrosis factor increases the number of epidermal growth factor receptors on human fibroblasts.

F. Maxfield, J. Vilček, S. Decker, 1987, The Journal of biological chemistry.

Action of interferon and its inducers aginst nonviral infectious agents.

J. Vilček, R. Jahiel, 1970, Archives of internal medicine.

CONCENTRATION AND PARTIAL PURIFICATION OF INTERFERON FROM MOUSE BRAINS.

J. Vilček, F. Sokol, L. Hána, 1964, Acta virologica.

Isolation and characterization of eight tumor necrosis factor-induced gene sequences from human fibroblasts

J. Vilček, T. Lee, E. Ziff, 1990, Molecular and cellular biology.

TNF/IL-1-inducible protein TSG-6 potentiates plasmin inhibition by inter-alpha-inhibitor and exerts a strong anti-inflammatory effect in vivo.

B. Cronstein, J. Vilček, B. Cronstein, 1996, Journal of immunology.

Accessory function of human fibroblasts in mitogen-stimulated interferon-gamma production by T lymphocytes. Inhibition by interleukin 1 and tumor necrosis factor.

J. Vilček, J. Le, 1987, Journal of immunology.

Construction and initial characterization of a mouse-human chimeric anti-TNF antibody.

B. Scallon, J. Ghrayeb, P. Daddona, 1993, Molecular immunology.

Therapeutic trial of interferon-gamma in patients with epidemic Kaposi's sarcoma.

J. Vilček, P. Rubinstein, J. Wernz, 1985, Journal of biological response modifiers.

REgulation of human interferon production stimulated with poly(I)-poly(C): correlation between shutoff and hyporesponsiveness to reinduction.

J. Vilček, M. Kohase, 1977, Virology.

Interferon research BC (before cloning).

J. Vilček, 2007, Current topics in microbiology and immunology.

Fifty years of interferon research: aiming at a moving target.

J. Vilček, 2006, Immunity.

Involvement of the IRF-1 transcription factor in antiviral responses to interferons.

T. Mak, J. Penninger, N. Tanaka, 1994, Science.

Critical role of a common transcription factor, IRF‐1, in the regulation of IFN‐beta and IFN‐inducible genes.

T. Taniguchi, J. Wolchok, H. Harada, 1992, The EMBO journal.

Inhibition of Tumor Necrosis Factor-induced p42/p44 Mitogen-Activated Protein Kinase Activation by Sodium Salicylate (*)

J. Vilček, E. Skolnik, P. Schwenger, 1996, The Journal of Biological Chemistry.

Inhibition of Sindbis Virus Plaque Formation by Extracts of Escherichia coli

J. Vilček, J. Freer, 1966, Journal of bacteriology.

STRUCTURE-FUNCTION STUDIES WITH HUMAN INTERFERON-GAMMA

J. Vilček, Y. Yip, P. Anderson, 1982 .

Partial characterization of gamma (immune) interferon mRNA extracted from human lymphocytes.

T. Taniguchi, J. Vilček, Y. Yip, 1981, Proceedings of the National Academy of Sciences of the United States of America.

Structure and function of human interferon-gamma.

J. Vilček, Y. Yip, J. Le, 1984, Symposium on Fundamental Cancer Research.

Intracellular location of newly synthesized interferon in human FS-4 cells.

J. Vilček, E. Falcoff, E. A. Havell, 1976, Virology.

Activation of p38 Mitogen-Activated Protein Kinase by Sodium Salicylate Leads to Inhibition of Tumor Necrosis Factor-Induced IκBα Phosphorylation and Degradation

J. Vilček, E. Skolnik, D. Alpert, 1998, Molecular and Cellular Biology.

Sequential suppression by actinomycin D of interferon production and cellular resistance induced by Poly I:C.

J. Vilček, F. Varacalli, 1971, The Journal of general virology.

Anti-malarial Effect of Interferon Inducers at Different Stages of Development of Plasmodium berghei in the Mouse

J. Vilček, J. Vanderberg, R. Nussenzweig, 1968, Nature.

Announcement: interferon nomenclature.

R. Friedman, K. Zoon, J. Blalock, 1980, International journal of immunopharmacology.

Phosphorylation and Degradation α B κ of Tumor Necrosis Factor-Induced I InhibitionKinase by Sodium Salicylate Leads to Activation of p 38 Mitogen-Activated Protein

J. Vilček, E. Skolnik, D. Alpert, 1997 .

Monocyte Activation Following Systemic Administration of Granulocyte‐Macrophage Colony‐Stimulating Factor

J. Vilček, D. Peace, A. Chachoua, 1994, Journal of immunotherapy with emphasis on tumor immunology : official journal of the Society for Biological Therapy.

Tumor necrosis factor-induced activation and increased tyrosine phosphorylation of mitogen-activated protein (MAP) kinase in human fibroblasts.

Wei Li, J. Schlessinger, J. Vilček, 1993, The Journal of biological chemistry.

Profile of Xiaowei Zhuang, winner of the 2020 Vilcek Prize in Biomedical Science

J. Vilček, P. Nair, 2020, Proceedings of the National Academy of Sciences.

Differential effects of type I IFN and IFN-gamma on the binding of tumor necrosis factor to receptors in two human cell lines.

J. Vilček, R. Feinman, M. Tsujimoto, 1986, Journal of immunology.

Protodyne: an immunomodulatory protein component, prepared from bacillus subtilis

J. Meer, J. Vilček, C. Dinarello, 1991 .

HOW MANY INTERFERONS ARE THERE

J. Vilček, Y. Yip, C. Urban, 1981 .

Interferon induction with Newcastle disease virus in FS-4 cells: Effect of 5,6-dichloro-1-β-D-ribofuranosylbenzimidazole (DRB)

J. Vilček, M. Kohase, 2005, Archives of Virology.

Regulatory Functions of Interferons

Jan Vilcek, Ion Gresser, Thomas C. Merigan, 1980 .

Tumor necrosis factor and interleukin 1 can act as essential growth factors in a murine plasmacytoma line.

L. Reis, J. Vilček, J. Le, 1988, Lymphokine research.

Inhibition of growth of B16 murine malignant melanoma by exogenous interferon.

A. Kopf, R. Bart, J. Vilček, 1980, Cancer research.

Long pentraxins: an emerging group of proteins with diverse functions.

R. Abagyan, J. Vilček, T. Cardozo, 1996, Cytokine & growth factor reviews.

Antiviral action of tumor necrosis factor in human fibroblasts is not mediated by B cell stimulatory factor 2/IFN-beta 2, and is inhibited by specific antibodies to IFN-beta.

T. Hirano, L. Reis, J. Vilček, 1988, Journal of immunology.

Differential regulation of TSG‐14 expression in murine fibroblasts and peritoneal macrophages

D. Levy, L. Reis, J. Vilček, 2000, Journal of leukocyte biology.

Stimulation of lymphokine production by teleocidin, aplysiatoxin, and debromoaplysiatoxin.

J. Vilček, Y. Yip, C. Urban, 1983, Cellular immunology.

Tumor necrosis factor acts synergistically with autocrine interferon-beta and increases interferon-beta mRNA levels in human fibroblasts.

T. H. Lee, L. Reis, J. Vilček, 1989, The Journal of biological chemistry.

Lymphokine production by human T cell hybridomas.

J. Vilček, W. Prensky, M. Sarngadharan, 1983, Journal of Immunology.

Immunologically specific production of interferon in cultures of rabbit blood lymphocytes: association with in vitro tests for cell-mediated immunity

J. Vilček, H. Bartfeld, 1975, Infection and immunity.

The importance of having gamma.

J. Vilček, 1982, Interferon.

Cloning and expression of a novel variant of human interferon-gamma cDNA.

T. Nishi, T. Oka, J. Vilček, 1985, Journal of biochemistry.

Regulation of metallothionein gene expression by TNF-α and IFN-β in human fibroblasts

J. Vilček, P. Sciavolino, 1995 .

Up-regulation of cyclooxygenase-2 expression by TSG-6 protein in macrophage cell line.

J. Vilček, H. Wisniewski, C. Mindrescu, 2005, Biochemical and biophysical research communications.

Generation of nitric oxide and clearance of interferon-gamma after BCG infection are impaired in mice that lack the interferon-gamma receptor.

J. Vilček, M. Aguet, R. Kamijo, 1995, Journal of inflammation.

Inhibition of interferon secretion by vinblastine

J. Vilček, E. Havell, 1975, The Journal of cell biology.

Formation and Properties of Interferon in the Brain of Tick-Borne Encephalitis Virus-Infected Mice.

J. Vilček, D. Stanček, 1963 .

Mass production and some characteristics of human interferon from diploid cells.

J. Vilček, E. Havell, 1974, In vitro. Monograph.

Interferon as a cell product.

J. Vilček, 1979, Advances in experimental medicine and biology.

Profile of Alexander Y. Rudensky, winner of the 2018 Vilcek Prize in Biomedical Science

J. Vilček, P. Nair, 2018, Proceedings of the National Academy of Sciences.

Recent progress in the elucidation of interferon-gamma actions: molecular biology and biological functions.

J. Vilček, I. Oliveira, 1994, International archives of allergy and immunology.

Knockouts of Interferons, Interferon Receptors and Interferon Signaling Components

L. Reis, J. Vilček, M. Aguet, 1998 .

Immunological profile of amyotrophic lateral sclerosis patients and their cell-mediated immune responses to viral and CNS antigens.

S. Wallenstein, J. Vilček, R. Carp, 1982, Clinical and experimental immunology.

Studies on an Interferon from Tick-Borne Encephalitis Virus-Infected Cells ( IF ). I. Appearance of IF in Infected Chick Embryo Cell Cultures.

J. Vilček, 1961 .

Boosting p53 with interferon and viruses

J. Vilček, 2003, Nature Immunology.

Pharmacokinetic Properties ofHumanFibroblast and Leukocyte Interferon inRabbits

J. Vilček, Y. Yip, I. Sulea, 1980 .

Morphogenesis of rabbit fibroma virus. Correlation with pathogenesis of the skin lesion.

J. Vilček, P. Prose, A. Friedman-kien, 1971, The American journal of pathology.

The Uptake of a Labeled Double-Stranded Polynucleotide by Cultured Rabbit Kidney Cells: An Electron Microscopic Study

J. Vilček, P. Prose, A. Friedman-kien, 1970, The Journal of general physiology.

Mitogenic effect of double‐stranded RNA in human fibroblasts: Role of autogenous interferon

J. Vilček, J Vilcek, M Kohase, 1987, Journal of cellular physiology.

Studies on the enhancement of interferon production in human diploid (FS-4) cells by ultraviolet.

J. Vilček, M. Kohase, 1978, Japanese journal of medical science & biology.

Temperature-sensitive interferon production in rabbit kidney cell cultures treated with toyocamycin.

J. Vilček, M. Ng, 1973, Biochimica et biophysica acta.

Membrane-bound intracellular interferon in rabbit kidney cell cultures.

J. Vilček, B. Berman, M. Nu, 1972, Virology.

The inauguration of Cytokine & Growth Factor Reviews.

M. Sporn, J. Vilček, 1996, Cytokine & growth factor reviews.

Requirement for transcription factor IRF-1 in NO synthase induction in macrophages.

T. Taniguchi, H. Harada, Tohru Kimura, 1994, Science.

Profile of Lily and Yuh Nung Jan, winners of the 2017 Vilcek Prize in Biomedical Science

Prashant Nair, Jan Vilcek, J. Vilček, 2017, Proceedings of the National Academy of Sciences.

The molluscum contagiosum virus in chick embryo cell cultures: an electron microscopic study.

J. Vilček, P. Prose, A. Friedman-kien, 1969, The Journal of investigative dermatology.

Effect of rabbit interferon on immune responses.

J. Vilček, G. Thorbecke, A. Friedman-kien, 1974, Cellular immunology.

Correlation of physicohemical and antigenic properties of human leukocyte interferon subspecies

J. Vilček, E. Havell, Y. Yip, 2005, Archives of Virology.

ANTIGENIC, PHYSICOCHEMICAL, AND BIOLOGIC CHARACTERIZATION OF HUMAN INTERFERONS *

J. Vilček, E. A. Havell, S. Yamazaki, 1977, Annals of the New York Academy of Sciences.

The Long Road To Renown: The 2015 Vilcek Foundation Prizes

Prashant Nair, Jan Vilcek, J. Vilček, 2015, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Control of Inducible Nitric Oxide Synthase Gene Expression by Interferon Regulatory Factor-1: Implications for Host Resistance to Bacteria and Viruses

J. Vilček, R. Kamijo, M. Bosland, 1996 .

Mice that lack the interferon-gamma receptor have profoundly altered responses to infection with Bacillus Calmette-Guerin and subsequent challenge with lipopolysaccharide

J. Vilček, M. Aguet, R. Kamijo, 1993, The Journal of experimental medicine.

Defective gamma-interferon production in peripheral blood leukocytes of patients with acute tuberculosis

J. Vilček, A. Klion, A. Friedman-kien, 1986, Journal of Clinical Immunology.

Coproduction of interleukin-2 and interferon-gamma in human mononuclear cells.

J. Vilček, M. Palladino, H. Oettgen, 1983, Journal of biological response modifiers.

Interferon: Effects On The Immune Response And The Mechanism Of Activation Of The Cellular Respons

S. Baron, J. Vilček, H. Johnson, 1976 .

Activation of p38 Mitogen-Activated Protein Kinase by Sodium Salicylate Leads to Inhibition of Tumor Necrosis Factor-Induced IκBα Phosphorylation and Degradation

J. Vilček, E. Skolnik, D. Alpert, 1998, Molecular and Cellular Biology.